BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 22
• 23
• 24
• 29
• 30

• BioForest

  DiaMedica Inc. Accelerates Warrant Expiry Date

  November 22, 2010

   · 

  5 min read
• ALR Technologies Inc. Announces Submission of Comments to Centers for Medicare & Medicaid Services on Proposed Policy for Glucose Monitors for Diabetes

  November 22, 2010

   · 

  2 min read
• Business

  Convergence Pharmaceuticals and Selcia Limited Announce Drug Discovery Collaboration Around Chronic Pain

  November 22, 2010

   · 

  4 min read
• TTP LabTech Ltd. Release: Mirrorball to Shine Across 2011 Conferences

  November 22, 2010

   · 

  1 min read
• Pharm Country

  Invivodata, Inc. Opens Registration for Annual Patient Reported Outcomes Conference

  November 22, 2010

   · 

  3 min read
• Business

  f-Star and Boehringer Ingelheim Corporation to Collaborate in Discovery and Development of Therapeutic Antibodies; Deal Could be Worth Over 1.2 Billion Euros

  November 22, 2010

   · 

  3 min read
• Drug Development

  Bayer Corporation and Regeneron Pharmaceuticals, Inc. Report Positive Top-Line Results of Two Phase 3 Studies with VEGF Trap-Eye in Wet Age-related Macular Degeneration

  November 22, 2010

   · 

  12 min read
• Drug Development

  FibroGen, Inc. Announces Phase 2A Results for Investigational Oral Anemia Therapy FG-4592 Will Be Presented at American Society of Nephrology Renal Week

  November 22, 2010

   · 

  1 min read
• Pharm Country

  Infinity Pharmaceuticals Inc. to Present at Piper Jaffray Healthcare Conference

  November 22, 2010

   · 

  1 min read
• Drug Development

  Alexion Pharmaceuticals Inc. Releas: Phase 2 Study of Eculizumab (Soliris(R)) in Patients with aHUS Resistant to Plasma Therapy Met Primary and Secondary Endpoints with High Statistical and Clinical Significance

  November 22, 2010

   · 

  1 min read